Month: June 2025

One-time Amtagvi Treatment Continues to Show Deep, Durable Responses and Meaningful Survival One Third of Responses Remain Ongoing without Subsequent Treatment after Five Years Simultaneous Presentation at ASCO 2025 SAN CARLOS, Calif., June 02, 2025 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today announced that the Journal of Clinical Oncology has published the final analysis from the Phase 2 C-144-01 clinical trial evaluating the individualized T cell therapy Amtagvi® (lifileucel) in patients with advanced melanoma. These five-year follow-up results are being simultaneously presented during an oral session today at the 2025 American...

ATHENS, Greece, June 02, 2025 (GLOBE NEWSWIRE) — OceanPal Inc. (NASDAQ: OP) (the “Company”), a global shipping company specializing in the ownership of vessels, today announced that, through a separate wholly-owned subsidiary, it has signed a Memorandum of Agreement to sell the 2004-built dry bulk vessel “Protefs” to a third party, for a sale price of US$7 million before commissions with delivery to the buyer no later than June 17, 2025. Upon completion of the aforementioned sale, OceanPal Inc.’s fleet will consist of 2 Panamax dry bulk vessels and an MR2 tanker vessel. A table describing the current OceanPal Inc. fleet can be found on the Company’s website, www.oceanpal.com. Information contained on the Company’s website does not constitute a part of this press release. About the Company OceanPal Inc. is a global provider of shipping...

Deployment Strengthens Company’s Position as Leading Provider of AI-Powered Screening Solutions for Critical InfrastructureShipment of another Sentinel Fixed Gantry CT underway — advancing AI-powered security screening across critical infrastructureShipment of another Sentinel Fixed Gantry CT underway — advancing AI-powered security screening across critical infrastructureShipment of another Sentinel Fixed Gantry CT underway — advancing AI-powered security screening across critical infrastructure Atlanta, GA, June 02, 2025 (GLOBE NEWSWIRE) — ScanTech AI Systems Inc. (the “Company” or “ScanTech AI”) (Nasdaq: STAI),  a leading innovator in advanced security screening technologies, today announced the successful delivery of its sixth Sentinel Fixed-Gantry CT system under a $3.5 million contract awarded...

AB “Ignitis grupė” (hereinafter – the Group) informs that on 2 June 2025 it has signed a financing agreement with the European Bank for Reconstruction and Development for a loan of EUR 60 million (hereinafter – the Loan), which will be used by its subsidiary UAB “Ignitis” to develop a public EV fast charging network in the Baltics. The Loan is granted for a period of 10 years. The other terms and conditions of the Loan are standard for corporate financing. The Loan will finance the installation of up to 600 EV fast charging stations across Lithuania, Latvia and Estonia by the end of 2027. The project investments are estimated at around EUR 76 million. Additionally, the Group secured the right to a grant of up to EUR 3.78 million under the Connecting Europe Facility’s programme Transport Alternative Fuels Infrastructure Facility. The...

AB “Ignitis grupė” (hereinafter – the Group) informs that on 2 June 2025 it has signed a financing agreement with the European Bank for Reconstruction and Development for a loan of EUR 60 million (hereinafter – the Loan), which will be used by its subsidiary UAB “Ignitis” to develop a public EV fast charging network in the Baltics. The Loan is granted for a period of 10 years. The other terms and conditions of the Loan are standard for corporate financing. The Loan will finance the installation of up to 600 EV fast charging stations across Lithuania, Latvia and Estonia by the end of 2027. The project investments are estimated at around EUR 76 million. Additionally, the Group secured the right to a grant of up to EUR 3.78 million under the Connecting Europe Facility’s programme Transport Alternative Fuels Infrastructure Facility. The...

Fit-for-purpose Facility Will Provide Significant Operational Flexibility as the Company Continues to Execute on its Long-Term Growth Strategy LIVERMORE, Calif., June 02, 2025 (GLOBE NEWSWIRE) — FormFactor, Inc. (NASDAQ: FORM), a leading provider of test and measurement technologies for the semiconductor industry, today announced that it has purchased a manufacturing site in Farmers Branch, Texas. The site, which comprises four structures and includes 50,000 square feet of clean room space, was purchased for $55 million dollars. Commenting on the purchase, Mike Slessor, CEO of FormFactor, Inc., said, “FormFactor’s purchase of the Farmers Branch, Texas manufacturing facility enables us to acquire a scarce, fit-for-purpose asset that aligns with our strategic roadmap and provides significant operational flexibility. Located in a...

WASHINGTON, June 02, 2025 (GLOBE NEWSWIRE) — ASP Isotopes Inc. NASDAQ: ASPI (“ASP Isotopes” or the “Company”), today announced the pricing of an underwritten registered direct offering of 7,518,797 shares of its common stock at a price of $6.65 per share to a single fundamental institutional investor. The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be approximately $50.0 million. The offering is expected to close on or about June 3, 2025, subject to the satisfaction of customary closing conditions. Cantor and Canaccord Genuity acted as joint book-running managers for the offering. The net proceeds of this offering are expected to be used for general corporate purposes, including working capital, operating expenses, and capital expenditures,...

Barnes v. Felix expands window of liability to include the totality of circumstances—renewing focus on officer’s actions during the pre-escalation period. MIAMI, June 02, 2025 (GLOBE NEWSWIRE) — Wrap Technologies, Inc, (NASDAQ: WRAP) (“Wrap” or, the “Company”), a global leader in innovative public safety technologies and non-lethal tools, today issues a letter to stockholders from Founder and CEO, Scot Cohen. Chairman and CEO Letter to Stockholders Fellow Stockholders, Law-enforcement tools, technologies, and tactics are under constant scrutiny—not just for their effectiveness, but for how they’re viewed by the public we serve. As public perception and the legal landscape evolves, law enforcement officers and leaders are challenged to keep up, balancing their constitutional oath to protect and the reality of operational readiness...

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the Jefferies Global Healthcare Conference 2025, which will be held in New York, New York June 3-5, 2025. Members of the management team will host one-on-one meetings at the conference. Dr. Balaji Prasad, Chief Strategy Officer will deliver a presentation with recent business updates at the conference on Thursday June 5, 2025, at 10:30 am-11:00 am EDT (14:30-15:00 GMT / 16:30-17:00 CET). A live video webcast of the presentation will be available to the general public and can be accessed at https://investors.alvotech.com/events/event-details/jefferies-global-healthcare-conference-nyc-2025. After the event, a recording will be available for replay for 90 days. About...

REYKJAVIK, Iceland, June 02, 2025 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the Jefferies Global Healthcare Conference 2025, which will be held in New York, New York June 3-5, 2025. Members of the management team will host one-on-one meetings at the conference. Dr. Balaji Prasad, Chief Strategy Officer will deliver a presentation with recent business updates at the conference on Thursday June 5, 2025, at 10:30 am-11:00 am EDT (14:30-15:00 GMT / 16:30-17:00 CET). A live video webcast of the presentation will be available to the general public and can be accessed at https://investors.alvotech.com/events/event-details/jefferies-global-healthcare-conference-nyc-2025. After the...